Presentation THT 2022 Changes in Voice Patterns for Monitoring Volume Status (Cardio) Presenter: Chaim Lotan February 01, 2022 REGISTER for free or LOG IN to view this content Heart Failure THT 2022 Heart Failure Up Next Presentation THT 2022 Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease Presenter: Barry Greenberg February 01, 2022 More slides + Presentation THT 2022 PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Roham Zamanian February 01, 2022 Presentation THT 2022 WhiteSwell Presenter: Sitaramesh Emani February 01, 2022 We Recommend Disclosures Nothing to disclose
Presentation THT 2022 Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease Presenter: Barry Greenberg February 01, 2022
Presentation THT 2022 PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Roham Zamanian February 01, 2022